Vaccinex (VCNX) Receives $6.2M From Warrant Exercise

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FICO
6. CART
7. LLY
8. TSLA
9. AZN
10. FLG

Go back to Vaccinex (VCNX) Receives $6.2M From Warrant Exercise

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

September 18, 2024 8:30 AM EDT

ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (Vaccinex or the Company), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease by blocking astrogliosis and neuroinflammation through the inhibition of SEMA4D, announced today the entry into definitive agreements for the immediate exercise of outstanding warrants to purchase an aggregate of 1,067,492 shares of common stock (the Existing Warrants) at the reduced exercise price of $5.636 per share, resulting in the issuance of 827,483 shares and the pre-funding of 240,009 shares.

In consideration for the immediate... More